AMD Biotech
Private Company
Total funding raised: $264K
Overview
AMD Biotech is a private, established player in the molecular diagnostics sector, leveraging genetics and genomics to create tests for infectious diseases and genetic conditions. Based in the biotech hub of San Diego, the company has likely progressed beyond the pre-revenue stage given its founding year and description as a developer and manufacturer. Its strategic focus on two high-demand diagnostic areas positions it within growing markets, though specific details on its technology and pipeline are not publicly disclosed without website content.
Technology Platform
Inferred to be a molecular diagnostics platform potentially utilizing PCR, NGS, and/or microarray technologies for detecting pathogens and genetic variants.
Pipeline
1| Drug | Indication | Stage | Watch |
|---|---|---|---|
| add-on pioglitazone + add-on sulphonylurea | Type 2 Diabetes Mellitus | Approved |
Funding History
1Opportunities
Risk Factors
Competitive Landscape
Operates in the highly competitive molecular diagnostics market, competing against global giants like Roche, Abbott, and Qiagen, as well as numerous specialized startups. Differentiation requires continuous innovation in test accuracy, speed, cost, and ease-of-use.